Prospective Outcomes After 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma

At 6 months, 97% of tumors (33/34) demonstrated clinical clearance, and all 33 tumors remained free of recurrence at 12 months. Scar outcomes were favorable, with mean POSAS patient and observer scores of 2.96 and 3.8 (on a 10-point scale), respectively. The 1064 nm Nd:YAG laser represents a promising, cosmetically favorable, and minimally invasive therapeutic option for BCC, particularly in patients who are suboptimal surgical candidates or who prefer non-surgical interventions.